The first study A Double-Blind, Placebo-Controlled Study of Repetitive Transnasal Sphenopalatine Ganglion Blockade With Tx360® as Acute Treatment for Chronic Migraine addresses the use of the Tx360® Nasal Applicator and it's effectiveness in clinical testing. The article is from the Headache: The Journal of Head and Face Pain.
Read the abstract Click Here.
The second study A Novel Revision to the Classical Transnasal Tropical Sphenopalatine Ganglion Block Treatment of Headache and Facial Pain the study addresses the use of the Tx360® Nasal Applicator and it's effectiveness in clinical testing. This study has been printed by the Pain Physicians Journal: Offical Journal of the American Society of Interventional Pain Physicians.
The study concludes that the relief experienced by patients from the techniques used by the MiRx Protocol significantly reduces migraine and head pain. Also the ease of the Tx360® proved to be an excellent method of application for pain specialists, the board also concluded that the they believe the Tx360® could be used in the busiest of primary care and emergency department settings. The SPG block with the Tx360® provides for a fast, inexpensive, easy-to-use intervention in a variety of environments.
To read abstract Click Here.